MarketInOut Stock Screener Log In | Sign Up

Senores Pharmaceuticals Ltd

BSE • Healthcare • Drug Manufacturers - General • Quote as of 10/27/2026 15:53
Senores Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeBSE
Market Capitalization55,904 mln
Float21.09 mln
Earnings Date10/29/2026

EPS

28.39
Exceptional

P / E

46.26
High premium

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-1.35
Manipulation likely

1-Year Forecast

1,613.60
Attractive

Relative Strength

70 / 100
Outperforming

Business Description

Senores Pharmaceuticals Limited is an India-based company that makes and sells a wide range of medicines across markets including the United States, the United Kingdom, Canada, and other countries. Its product lineup covers treatments for pain, infections, heart conditions, diabetes, cancer, and many other health needs, along with vitamins and nutritional supplements. Founded in 2017 and headquartered in Ahmedabad, the company also offers management and consulting services.

Key Fundamentals

EPS28.39
P/E46.26
ROE14.96
RPS151
ROIC13.31
ROA9.16
Interest Cover6.25
EBITDA, mln2,344
EV / EBITDA28.48
EV / EBIT33.52
Revenue, mln6,917
EV / Revenue9.65

Quote Details

Last 1,313.20
Change 65.85 (5.28%)
Open 1,255.00
Volume 13,372
Turnover 17,560,110
Average Volume 11,335

Financial Ratios

Pre-Tax Profit Margin25
Current Ratio1.92
Price / Book6.61
Price / Tangible Book11.02
Debt / Equity0.37
Price / Sales9.25

Financial Strength

Altman Z-Score7.36
Piotroski F-Score 5 / 9
Beneish M-Score-1.35
Price to Graham Number5.20
1-Year Target Price1,613.60

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.85% 93 / 100   
1 Month -2.29% 71 / 100   
2 Months -5.25% 58 / 100   
6 Months 48.73% 92 / 100   
1 Year 77.66% 95 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog